Early growth and non-alcoholic fatty liver disease in adulthood - The NAFLD liver fat score and equation applied on the Helsinki Birth Cohort Study

Annals of Medicine

Volumn 45, Issue 5-6, 2013, Pages 430-437

  Sandboge, Samuel ^a,b   Perälä, Mia Maria ^b   Salonen, Minna K ^a,b   Blomstedt, Paul A ^b   Osmond, Clive ^c   Kajantie, Eero ^b   Barker, David J P ^c   Eriksson, Johan G ^a,b,d,e,f  

^a FOLKHÄLSAN RESEARCH CENTER   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d UNIVERSITY OF HELSINKI   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f VAASA CENTRAL HOSPITAL   (Finland)

Author keywords

Algorithms; Fatty liver; Foetal programming; Liver disease

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BODY MASS; BODY SIZE; CALORIC INTAKE; CHILD; CHILD GROWTH; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAFLD LIVER FAT SCORE; NONALCOHOLIC FATTY LIVER; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM; SOCIAL STATUS;

ADULT; BODY FAT DISTRIBUTION; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FATTY LIVER; FEMALE; FINLAND; HUMANS; INFANT, NEWBORN; LIVER; MALE; MIDDLE AGED; OBESITY;

EID: 84882326716     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2013.801275     Document Type: Article

References (45)

1. Lillycrop K, Hanson M, Burdge 1. G. Epigenetics and the infl uence of maternal diet. In : Newnham J, Ross M, editors. Early life origins of human health and disease. Basel: Karger; 2009. p. 11- 20
2. Godfrey KM, Gluckman PD, Hanson MA. Developmental origins of metabolic disease: Life course and intergenerational perspectives . Trends Endocrinol Metab. 2010; 21: 199- 205
3. Whincup PH, Kaye SJ, Owen CG, Huxley R, Cook DG, Anazawa S, et al. Birth weight and risk of Type 2 diabetes. JAMA. 2008; 300: 2886- 97
4. Andersen LG, Ä ngquist L, Eriksson JG, Forsen T, Gamborg M, Osmond C, et al . Birth weight, childhood body mass index and risk of coronary heart disease in adults: Combined historical cohort studies. PLoS One. 2010; 5: E14126
5. Eriksson J, Forsen T, Tuomilehto J, Winter P, Osmond C, Barker D. Catch-up growth in childhood and death from coronary heart disease: Longitudinal study . BMJ. 1999; 318: 427- 31
6. Barker DJP, Osmond C, Kajantie E, Eriksson JG. Growth and chronic disease: Findings in the Helsinki Birth Cohort . Ann Hum Biol. 2009 ; 36 : 445-58
7. Fors é n T, Eriksson J, Tuomilehto J, Reunanen A, Osmond C, Barker D. The fetal and childhood growth of persons who develop type 2 diabetes. Ann Intern Med. 2000; 133: 176- 82
8. E riksson J G. E arly growth and coronary heart disease and type 2 diabetes: Findings from the Helsinki Birth Cohort Study (HBCS). Am J Clin Nutr. 2011; 94: 1799S- 802S.
9. Puri P, Sanyal AJ. Nonalcoholic fatty liver disease: Defi nitions, risk factors, and workup . Clinical Liver Disease. 2012; 1: 98- 102
10. Levene AP, Goldin RD. The epidemiology, pathogenesis and histopathology of fatty liver disease. Histopathology. 2012; 61: 141- 52
11. Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of nonalcoholic fatty liver disease. Dig Dis. 2010; 28: 155- 61
12. Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity . Ann Med. 2011 ; 43 : 617-49
13. Nakao H, Yoneda M. The intertwisted correlations among non-alcoholic fatty liver disease, atherosclerosis, and metabolic syndrome . J Gastroenterol. 2009; 44: 1162- 4
14. Vanni E, Bugianesi E, Kotronen A, De Minicis S, Yki-J ä rvinen H, Svegliati-Baroni G . From the metabolic syndrome to NAFLD or vice versa? Dig Liver Dis. 2010 ; 42 : 320-30
15. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al . Nonalcoholic fatty liver disease a feature of the metabolic syndrome. Diabetes. 2001; 50: 1844- 50
16. L ewis J R, M ohanty S R. N onalcoholic fatty liver disease: A review and update. Dig Dis Sci. 2010; 55: 560- 78
17. Nobili V, Marcellini M, Marchesini G, Vanni E, Manco M, Villani A, et al. Intrauterine growth retardation, insulin resistance, and nonalcoholic fatty liver disease in children. Diabetes Care. 2007; 30: 2638- 40
18. Fraser A, Ebrahim S, Davey Smith G, Lawlor DA. The associations between birthweight and adult markers of liver damage and function. Paediatr Perinat Epidemiol. 2007; 22: 12- 21
19. Hyatt M, Gardner D, Sebert S, Wilson V, Davidson N, Nigmatullina Y, et al . Suboptimal maternal nutrition, during early fetal liver development, promotes lipid accumulation in the liver of obese off spring. Reproduction. 2011; 141: 119- 26
20. Bruce KD, Cagampang FR, Argenton M, Zhang J, Ethirajan PL, Burdge GC, et al. Maternal high-fat feeding primes steatohepatitis in adult mice off spring, involving mitochondrial dysfunction and altered lipogenesis gene expression. Hepatology. 2009; 50: 1796- 808
21. Oben JA, Mouralidarane A, Samuelsson AM, Matthews PJ, Morgan ML, Mckee C, et al . Maternal obesity during pregnancy and lactation programs the development of off spring non-alcoholic fatty liver disease in mice. J Hepatol. 2010; 52: 913- 20
22. Morrison JL, Duffi eld JA, Muhlhausler BS, Gentili S, McMillen IC. Fetal growth restriction, catch-up growth and the early origins of insulin resistance and visceral obesity . Pediatr Nephrol. 2010; 25: 669- 77
23. Barker DJP, Forsen T, Eriksson JG, Osmond C. Growth and living conditions in childhood and hypertension in adult life: A longitudinal study. J Hypertens. 2002; 20: 1951- 6
24. Forsen T, Eriksson J, Tuomilehto J, Teramo K, Osmond C, Barker D. Mother ' s weight in pregnancy and coronary heart disease in a cohort of Finnish men: Follow up study . BMJ. 1997; 315: 837- 40
25. K unst A, D raeger B, Z iegenhorn J . U V-methods with hexokinase and glucose-6-phosphate dehydrogenase . Methods of Enzymatic Analysis. 1983 ; 6 : 163-72
26. Sobey WJ, Beer S, Carrington CA, Clark P, Frank B, Gray I, et al. Sensitive and specifi c two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins . Biochem J. 1989 ; 260 : 535-41
27. Consultation W. Defi nition, diagnosis and classifi cation of diabetes mellitus and its complications . Geneva, Switzerland: World Health Organization; 1999 . p. 31-3
28. Alberti K, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al . Harmonizing the metabolic syndrome. A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation . 2009 ; 120 : 1640-5
29. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al . The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association . Hepatology. 2012 ; 55 : 2005-23
30. Kotronen A, Peltonen M, Hakkarainen A, Sevastianova K, Bergholm R, Johansson LM, et al . Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors . Gastroenterology. 2009 ; 137 : 865-72
31. Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al . The Fatty Liver Index: A simple and accurate predictor of hepatic steatosis in the general population . BMC Gastroenterol. 2006; 6 : 33
32. Pajunen P, Kotronen A, Korpi-Hy ö v ä lti E, Kein ä nen-Kiukaanniemi S, Oksa H, Niskanen L, et al . Metabolically healthy and unhealthy obesity phenotypes in the general population: The FIN-D2D Survey . BMC Public Health. 2011; 11 : 754
33. Palekar NA, Naus R, Larson SP, Ward J, Harrison SA. Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease . Liver Int. 2006 ; 26 : 151-6
34. Wieckowska A, Feldstein AE. Diagnosis of nonalcoholic fatty liver disease: Invasive versus noninvasive . Semin Liver Dis. 2008 ; 28 : 386-95
35. W eigand K, W eigand K . P ercutaneous liver biopsy: Retrospective study over 15 years comparing 287 inpatients with 428 outpatients . J Gastroenterol Hepatol. 2009; 24: 792- 9
36. Rold á n-Valadez E, Favila R, Mart í nez-L ó pez M, Uribe M, M éndez-Sá nchez N . Imaging techniques for assessing hepatic fat content in nonalcoholic fatty liver disease. Ann Hepatol. 2008; 7: 212- 20
37. Miller MH, Ferguson MAJ, Dillon JF. Systematic review of performance of non-invasive biomarkers in the evaluation of non-alcoholic fatty liver disease. Liver Int. 2011; 31: 461- 73
38. Patel K. Noninvasive tools to assess liver disease. Curr Opin Gastroenterol. 2010; 26: 227- 33
39. Musso G, Gambino R, Durazzo M, Cassader M. Noninvasive assessment of liver disease severity with liver fat score and CK-18 in NAFLD: Prognostic value of liver fat equation goes beyond hepatic fat estimation. Hepatology. 2010; 51: 715- 17
40. B alkau B, L ange C, V ol S, F umeron F, B onnet F. N ine-year incident diabetes is predicted by fatty liver indices: The French D.E.S.I.R. study. BMC Gastroenterol. 2010; 10: 56
41. Paalanen L, M ä nnist ö S, Virtanen MJ, Knekt P, R ä s ä nen L, Montonen J, et al . Validity of a food frequency questionnaire varied by age and body mass index. J Clin Epidemiol. 2006; 59: 994- 1001
42. M ä nnist ö S, Virtanen M, Mikkonen T, Pietinen P. Reproducibility and validity of a food frequency questionnaire in a case-control study on breast cancer . J Clin Epidemiol. 1996; 49: 401- 9
43. Eriksson JG, Forsen T, Tuomilehto J, Osmond C, Barker DJP. Early growth and coronary heart disease in later life: Longitudinal study . BMJ. 2001 ; 322 : 949-53
44. Kajantie E, Osmond C, Barker DJ, Fors é n T, Phillips DI, Eriksson JG. Size at birth as a predictor of mortality in adulthood: A follow-up of 350000 person-years . Int J Epidemiol. 2005; 34: 655- 63
45. Gluckman PD, Hanson MA, Beedle AS. Early life events and their consequences for later disease: A life history and evolutionary perspective. Am J Hum Biol. 2007; 19: 1- 19